{ "items": [ "\n\n
\n \n 28 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nOUCRU research article titled \u2018Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes\u2019 was recently awarded the 2021-2022 Alexandre Yersin Prize for Outstanding Publications.
\n \n\n\n \n 21 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n \n \n OUCRU-Nepal\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nHealthcare workers and community members in Indonesia, Nepal and Vietnam have been documenting their personal experiences of Covid-19. They have each made their own \u2018digital diary\u2019, using a range of creative tools and with technical support from the project team. These diaries form part of the SPEAR project: exploring the experiences and impacts of COVID-19 for healthcare workers and vulnerable communities.
\n \n\n\n \n 21 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n \n \nSanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.
\n \n\n\n \n 8 June 2022\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n KWTRP\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nOur heartfelt congratulations to Melissa Kapulu, Francis Ndungu and Emelda Okiro from KWTRP, and to Hoa Thi Ngo and Sophie Yacoub from OUCRU who have been awarded Associate Professorships
\n \n\n\n \n 24 May 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nA first-of-its kind randomised controlled trial compared two different antitoxin treatments for tetanus. A comparison of human and equine intramuscular antitoxin in adults found that intramuscular equine antitoxin is safe and effective for treating tetanus in adults. Addition of additional intrathecal (spinal) antitoxin does not add any benefit compared to treatment with intramuscular antitoxin alone.
\n \n\n\n \n 26 April 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Eijkman Oxford Clinical Research Unit in Indonesia and Sumba Foundation collaborated with photographer Yoppy Pieter to express the human face of leprosy in Sumba, a remote island in eastern Indonesia. The project aimed to visualize the story of leprosy and raise awareness of this debilitating and heavily stigmatised disease
\n \n\n\n \n 6 April 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n \n \nWhat do we mean by 'Research Culture' and how has fostering a multinational, collaborative culture helped us deliver world-class research? Let's explore the research culture at OUCRU.
\n \n\n\n \n 29 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n \n \n Public Engagement\n \n \n \n \n Video\n \n \n\n \n\n\n
\n \n\n \n \n \nWhy does OUCRU place an important focus on engaging with its important partners, policy makers, the press, the community, and young people? Explore our work in policy & public engagement.
\n \n\n\n \n 24 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nEach year on 24 March, World TB Day is commemorated to raise awareness of this devastating and deadly disease. The theme for this year\u2019s World TB Day is \u201cInvest to End TB. Save Lives\u201d, conveying the urgent need to invest resources to ramp up the fight against TB and achieve the commitments to end TB made by global leaders.
\n \n\n\n \n 22 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nA triple artemisinin-based combination therapy (TACT) of artemether-lumefantrine plus amodiaquine (AL+AQ) for uncomplicated falciparum malaria in areas with a high prevalence of artemisinin resistance is a well-tolerated, effective treatment for multidrug-resistant parasites, say a team of MORU-led researchers.
\n \n\n\n \n 22 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n \n \n Video\n \n \n\n \n\n\n
\n \n\n \n \n \nIn this video, explore OUCRU's research areas and what questions we are aiming to answer in the next 5 years.
\n \n\n\n \n 11 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n \n \n OUCRU-Nepal\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nIn the last two years, OUCRU has worked with our partners and collaborators to conduct various research and engagement projects in response to the COVID-19 pandemic. This portfolio provides an overview of all the on-going projects that our entire programme have been working on to contribute to the understanding and management of COVID-19 and its national, regional and global impact.
\n \n\n\n \n 11 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n \n \nAre you curious about what a leading regional research hub for infectious disease look like? OUCRU is a large-scale research programme with offices in Ho Chi Minh City, Hanoi (Vietnam) and Jakarta (Indonesia). In this video, our leading scientists will take you on a tour of OUCRU's facilities and introduce you to our host institutions: the Hospital for Tropical Diseases (Ho Chi Minh City, Vietnam), the National Hospital for Tropical Diseases (Hanoi, Vietnam), and the Eijkman Institute (Jakarta, Indonesia)
\n \n\n\n \n 4 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n \n \n OUCRU-Nepal\n \n \n\n \n\n\n
\n \n\n \n \n \nAfter over 30 years of working in infectious disease in Vietnam, Indonesia, and Nepal, OUCRU has developed and established its foothold as a crucial regional research hub in infectious diseases, bridging the gap between research and treatments all over the world. What have we done? How did we do it? And what will OUCRU continue to focus on in the next 5 years?
\n \n\n\n \n 1 March 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nOUCRU Public and Community Engagement Department has compiled a directory of services for Vietnamese communities and people living in Vietnam. Throughout the Covid-19 pandemic, OUCRU has been actively involved in Covid-19 diagnostics, treatment, research, health education, and community engagement. We have worked in collaboration with the Vietnamese Ministry of Health and respected medical and research institutes across Vietnam.
\n \n\n\n \n 18 February 2022\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford University Clinical Research Unit (OUCRU), a leading clinical and public health research unit, and Dragon Capital Group, an established financial institution focused on Vietnam and other Southeast Asian emerging markets, announced a two-year partnership to support the development of high-quality intensive care for those with life-threatening infectious diseases in Vietnam.
\n \n\n\n \n 19 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n KWTRP\n \n \n \n \n MORU\n \n \n \n \n OUCRU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nA downloadable resource for educators, health & research professionals to help develop young peoples\u2019 understanding of AMR and positive actions they can take to mitigate it.
\n \n\n\n \n 16 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n \n \n Public Engagement\n \n \n \n \n Video\n \n \n\n \n\n\n
\n \n\n \n \n \nUntil recently, Plasmodium falciparum dominated the malaria research landscape, and Plasmodium vivax infection was considered benign and inconsequential. We now know that this is not true: if not properly diagnosed and treated, P. vivax can lead to life-threatening syndromes and death. Professor Kevin Baird from EOCRU in Jakarta, Indonesia talks to OutBreak News Today
\n \n\n\n \n 10 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n \n \n OUCRU-Nepal\n \n \n\n \n\n\n
\n \n\n \n \n \nDespite unprecedented disruptions caused globally by SARS-Cov-2, OUCRU has responded remarkably and addressed almost every important aspect of the pandemic, from its societal impact to viral genomic surveillance and COVID-19 therapy
\n \n\n\n \n 2 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n NDM-CGHR\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n \n \nA new, extensive systematic review has identified significant research gaps in the treatment of scrub typhus which could be improved by developing a database for individual participant data (IPD) to enable more detailed analyses to address important knowledge gaps such as the optimum dosing for children and to improve patient outcomes.
\n \n\n\n \n 26 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nHopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.
\n \n\n\n \n 22 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nUsing cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis drug treatments.
\n \n\n\n \n 11 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n \n \nThe malaria parasite Plasmodium vivax causes frequent, chronic infections that represent a major unrecognized burden on global health, according to a review by Kevin Baird of the Eijkman-Oxford Clinical Research Unit in Indonesia and Katherine Battle of the Institute for Disease Modeling in the United States
\n \n\n\n \n 21 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nThe fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle\u2019s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include OUCRU in Vietnam and institutions in Canada, Chile, Australia and the UK. GPAS is also now part of the Public Health England New Variant Assessment Platform.
\n \n\n\n \n 14 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n KWTRP\n \n \n \n \n MORU\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nFollowing the meeting of the Medical Sciences Divisional Committee to consider applications for the conferral of the title of Associate Professor, we are pleased to announce that Rashan Haniffa, Dorcas Kamuya, Isabella Oyier, Le Van Tan and Timothy Walker have been awarded the title Associate Professor
\n \n\n\n \n 22 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nNguyen Lam Vuong, Sophie Yacoub & colleagues have identified a combination of biological markers in patients with dengue that could predict whether they go on to develop moderate to severe disease. Biomarkers are used to identify the state or risk of a disease in patients; these findings could aid the development of biomarker panels for clinical use and help improve triage and risk prediction in patients with dengue.
\n \n\n\n \n 17 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n \n \nA trial in infants and toddlers in Burkina Faso showed that experimental malaria vaccine R21/MM confers 77% protection, an unprecedented level and the first malaria vaccine to exceed WHO\u2019s goal of 75% efficacy. While a larger trial is needed to assess its safety and efficacy, R21/MM may substantially reduce child mortality in Sub-Saharan Africa. But this vaccine may be less relevant to Asia Pacific where malaria causes severe morbidity and mortality in all age groups, asymptomatic malaria infections are frequent, and the vaccine may not be effective against P. vivax.
\n \n\n\n \n 12 June 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n NDM-CGHR\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nThe pioneering work of members of the University of Oxford has been recognised in The Queen's Birthday Honours List. The honorands include Professor Peter Horby and six researchers that have played key roles in leading the University\u2019s response to the Coronavirus pandemic, from the development of new vaccines to the discovery of new drug treatments. Professor Guy Thwaites is appointed a Member of the Order of the British Empire.
\n \n\n\n \n 25 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Nepal\n \n \n\n \n\n\n
\n \n\n \n \n \nCOVID-19 in Nepal is out of hand and slowly, but surely tracking the infection in India. Although many healthcare workers have been vaccinated throughout the country, the actual vaccination rate is likely very low for the entire country. Buddha Basynat discusses Nepal\u2019s COVID response so far, and why vaccines are an urgent priority.
\n \n\n\n \n 14 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Nepal\n \n \n\n \n\n\n
\n \n\n \n \n \nDirector for the Oxford University Clinical Research Unit Nepal, Professor Buddha Basnyat is a medical doctor based in Kathmandu, Nepal. His research interests are infectious diseases and high altitude medicine, and he has almost 300 publications in peer-reviewed medical journals. One of his primary interests is to encourage young people to do clinical research.
\n \n\n\n \n 5 May 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Nepal\n \n \n\n \n\n\n
\n \n\n \n \n \nNepal is seeing a COVID surge that is proportionately similar to India. While we try to treat the sick by increasing hospital space and ensuring oxygen supply, we must also plan for an exit strategy. Over-preparation rather than under-preparedness needs to be our mantra, with widespread vaccination the key to get us out of this pandemic, by Professor Buddha Basnyat
\n \n\n\n \n 26 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nWorld Immunization Week highlights the role vaccinations play in improving the health of communities. As the COVID pandemic continues to impact countries worldwide, governments are facing challenges related to coverage, equity and sustainability of routine immunisation alongside access and the particular maintenance requirements related to the SARS-CoV-2 vaccines. Communication with communities has been key to ensure continued engagement with the vaccine programs despite the challenges of current contexts.
\n \n\n\n \n 21 April 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n \n \nAnuraj Shankar from our EOCRU unit in Jakarta, Indonesia, with Elizabeth Prado and Leila Larson describe a meta-analysis showing that responsive caregiving boosts infants\u2019 brain development. Parenting group sessions and home visits improve cognitive, language, and motor skills. And nutrition-only programmes have much less effect than comprehensive interventions.
\n \n\n\n \n 22 February 2021\n \n
\n\n \n\n \n\n \n \n \n \n NDM-CGHR\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n \n \n OUCRU-Nepal\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world\u2019s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.
\n \n\n\n \n 2 February 2021\n \n
\n\n \n\n \n\n \n \n \n \n MORU\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Indonesian government policy to exclude the elderly in the first phase of the COVID-19 vaccination program could hinder the vaccine\u2019s impact in lowering mortality rates. COVID-19 mortality rates in Indonesia, the highest in Southeast Asia, are dominated by those in the 60 years and above age bracket. In this article published in The Conversation, Kartika Saraswati and fellow DPhil students elaborate how, by prioritising vaccination for elderly, Indonesia may optimally reduce the hospital burden and COVID-19 deaths amidst a limited vaccine supply during the first vaccination phase.
\n \n\n\n \n 4 January 2021\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nCongratulations to Pearl Gan, OUCRU Photographer in Residence, for her winning image selected for the Lancet Highlights 2020: Framing Health Stories. Despite the difficulties of this pandemic year, The Lancet received fascinating and varied entries for our Highlights 2020 photography competition. 15 striking photographs were selected. Each picture captures a unique moment, highlighting a health story.
\n \n\n\n \n 23 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nThe YAAR! project, bringing together young people from four countries in the Global South to help combat the challenge of antimicrobial resistance (AMR), or drug resistant infections.
\n \n\n\n \n 23 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n \n \n KWTRP\n \n \n \n \n MORU\n \n \n \n \n NDM-CGHR\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford is world-famous for research excellence and home to some of the most talented people from across the globe. To showcase our global research, the University launched a Global Research Map, highlighting areas of research we are conducting overseas.
\n \n\n\n \n 24 September 2020\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Nepal\n \n \n\n \n\n\n
\n \n\n \n \n \nCovid-19 continues to cause huge disruption worldwide. As well as the ongoing immediate health impacts of the pandemic, its economic toll is being felt across the world, particularly in LMICs like Nepal. In addition to the wide-ranging disruption of health services, Covid-19 has shifted research priorities and stalled other essential ongoing research. Despite many problems, Covid-19 has afforded a unique opportunity for a better understanding of health research and methodologies in infectious diseases.
\n \n\n\n \n 1 September 2020\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nResistance to antibiotics is one of the key challenges to healthcare this century. Tackling it will require sweeping changes to antibiotic use in animals\u2060\u2014and researchers from Oxford University Clinical Research Unit are rising to the challenge in Vietnam, with a rigorous test of programmes among farmers.
\n \n\n\n \n 26 August 2020\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nThe World Mosquito Program posted the results of a 3-year randomised controlled trial in Yogyakarta, Indonedia, providing compelling gold standard evidence for the efficacy of the Wolbachia method in controlling dengue. The deployment of Wolbachia-carrying Aedes aegypti mosquitoes lead to a reduction of 77% in dengue incidence in Wolbachia-treated versus untreated areas.
\n \n\n\n \n 13 July 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n COMRU\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n \n \n OUCRU-Nepal\n \n \n\n \n\n\n
\n \n\n \n \n \nThis year has seen a high level of recognition of distinction in the Africa and Asia Programmes and Global Health research. Many congratulations to our researchers.
\n \n\n\n \n 3 July 2020\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Le Van Tan in OUCRU, in collaboration with the Hospital for Tropical Diseases and the Department of Health, has shown that it is common for people who are infected with the virus that causes COVID-19 (SARS-CoV-2) to have no symptoms whatsoever. By testing quarantined people in Vietnam, his team was able to detect asymptomatic individuals. The virus disappeared faster from the bodies of the asymptomatic carriers than from that of symptomatic individuals, but it appeared that some of them still managed to pass the infection on to others.
\n \n\n\n \n 1 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nDespite a long border with China and a population of 97 million people, Vietnam has recorded only just over 300 cases of Covid-19 and not a single death. The country very quickly enacted measures such as travel restrictions, monitoring and eventually closing border with China, closing schools and increasing health checks at borders and other vulnerable places. A vast and labour intensive contact tracing operation got under way. Quarantine on such a vast scale is key as evidence mounts that as many as half of all infected people are asymptomatic.
\n \n\n\n \n 16 March 2020\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n Public Engagement\n \n \n\n \n\n\n
\n \n\n \n \n \nThis community drama programme was designed by the OUCRU Public and Community Engagement group to raise awareness about the importance of vaccinations in remote areas of Binh Phuoc province. The majority of the population are ethnic minority groups with limited access to health promotion. Without even radio as a method of dissemination, home visits by local healthcare workers is the main way to encourage the community to get vaccinated. Scripted very closely to the context of everyday lives, this play helps understand more about vaccinations and explains how to access the National Expanded Programme on Immunization.
\n \n\n\n \n 20 December 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nIn recognition of her past contributions to the field of international infectious diseases and in anticipation of her future impact on the discipline, Sophie Yacoub, Dengue Research Group Head at OUCRU, Ho Chi Minh City, Vietnam, is recognised as ISID Emerging Leader in International Infectious Diseases.
\n \n\n\n \n 11 December 2019\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Nepal\n \n \n\n \n\n\n
\n \n\n \n \n \nA large field study of typhoid conjugate vaccine (TCV) in Nepal has shown a single dose to be safe and effective in reducing typhoid in children aged 9 months to <16 years in an endemic setting. OUCRU-Nepal Professor Buddha Basnyat took part in this study.
\n \n\n\n \n 6 December 2019\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nEarlier this year, OUCRU Photographer in Residence Pearl Gan conducted a project focusing on dengue. In that project, she took photos of dengue patients and health care workers at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam. She also took photos of dengue patients in their homes and at research sites in the city. This project was funded by the Wellcome Trust, and this week selected photos from that project have been published in The Lancet as a photo story.
\n \n\n\n \n 26 November 2019\n \n
\n\n \n\n \n\n \n \n \n \n OUCRU\n \n \n\n \n\n\n
\n \n\n \n \n \nMary Chambers (OUCRU Public Engagement Vietnam) and Gill Black (Sustainable Livelihood Foundation, South Africa) have partnered with The Global Health Network training centre to published this online course and handbook
\n \n\n\n \n 16 October 2019\n \n
\n\n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n OUCRU\n \n \n \n \n OUCRU-Indonesia\n \n \n\n \n\n\n
\n \n\n \n \n \nA mother and her baby leave a Puskesmas - a government-mandated primary care clinic - in West Java, Indonesia, following a check-up. The woman smiles, as the infant stares out from the safety of a bright sarong wrap. This quiet moment of active participation in their own health and well-being is the realisation of a fundamental human right. WHO\u2019s vision for primary health care in the 21st century is to ensure the highest possible level of health and well-being, with equitable distribution.
\n \n\n